Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy
Status:
Terminated
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of a new oral
immunosuppressant agent compared to standard care in renal transplant patients diagnosed with
BK nephropathy.